| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question—to treat or not to treat?
|
Cabillic, Florian
|
|
|
3 |
6 |
p.
|
artikel
|
| 2 |
BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance
|
Tarantelli, Chiara
|
|
|
3 |
6 |
p.
|
artikel
|
| 3 |
Biosimilars in oncology
|
Tabernero, Josep
|
|
|
3 |
6 |
p.
|
artikel
|
| 4 |
Cancer and the arts: a Pacifist’s Guide to the War on Cancer
|
Wagner, Wolfgang
|
|
|
3 |
6 |
p.
|
artikel
|
| 5 |
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysis
|
Garassino, Marina Chiara
|
|
|
3 |
6 |
p.
|
artikel
|
| 6 |
Correction: PO-194 Novel potential targets for hakai oncogene during tumour progression
|
|
|
|
3 |
6 |
p.
|
artikel
|
| 7 |
Correction: Preparing for the incoming wave of biosimilars in oncology
|
|
|
|
3 |
6 |
p.
|
artikel
|
| 8 |
ESMO 2018 presidential symposium—IMpassion130: atezolizumab+nab-paclitaxel in triple-negative breast cancer
|
Schmid, Peter
|
|
|
3 |
6 |
p.
|
artikel
|
| 9 |
Extra cost of brain metastases (BM) in patients with non-squamous non-small cell lung cancer (NSCLC): a French national hospital database analysis
|
Girard, Nicolas
|
|
|
3 |
6 |
p.
|
artikel
|
| 10 |
Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)
|
Dieci, Maria Vittoria
|
|
|
3 |
6 |
p.
|
artikel
|
| 11 |
Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
|
Banerjee, Susana
|
|
|
3 |
6 |
p.
|
artikel
|
| 12 |
Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer
|
Vansteenkiste, Johan F.
|
|
|
3 |
6 |
p.
|
artikel
|
| 13 |
In the literature: August 2018
|
Gambardella, Valentina
|
|
|
3 |
6 |
p.
|
artikel
|
| 14 |
In the literature: October 2018
|
Roda, Desamparados
|
|
|
3 |
6 |
p.
|
artikel
|
| 15 |
Precision oncology: separating the wheat from the chaff
|
Remon, Jordi
|
|
|
3 |
6 |
p.
|
artikel
|
| 16 |
Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy
|
Goto, Wataru
|
|
|
3 |
6 |
p.
|
artikel
|
| 17 |
Preparing for the incoming wave of biosimilars in oncology
|
Wolff-Holz, Elena
|
|
|
3 |
6 |
p.
|
artikel
|
| 18 |
Prognostic Nutritional Index: an easy nutritional screening for patients with head and neck cancer?
|
Bossi, Paolo
|
|
|
3 |
6 |
p.
|
artikel
|
| 19 |
Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer
|
Bruixola, Gema
|
|
|
3 |
6 |
p.
|
artikel
|
| 20 |
Report from the ESMO 2018 presidential symposium—Radiotherapy to the primary tumour for men with newly diagnosed metastatic prostate cancer: survival results from STAMPEDE
|
Parker, Chris
|
|
|
3 |
6 |
p.
|
artikel
|
| 21 |
Report on the status of women occupying leadership roles in oncology
|
Hofstädter-Thalmann, Eva
|
|
|
3 |
6 |
p.
|
artikel
|
| 22 |
Risk factors for the development of brain metastases in patients with HER2-positive breast cancer
|
Maurer, Christian
|
|
|
3 |
6 |
p.
|
artikel
|
| 23 |
Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme
|
Lindsay, Colin R.
|
|
|
3 |
6 |
p.
|
artikel
|
| 24 |
Tobacco smoking and cessation and PD-L1 inhibitors in non-small cell lung cancer (NSCLC): a review of the literature
|
Norum, Jan
|
|
|
3 |
6 |
p.
|
artikel
|
| 25 |
Tumor evolution in non-small-cell lung cancer
|
Parry, Marina
|
|
|
3 |
6 |
p.
|
artikel
|
| 26 |
Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer
|
Kusumoto, Tetsuya
|
|
|
3 |
6 |
p.
|
artikel
|
Tijdschrift beschrijving